Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing
- Product NDC
- 49967-307
- 11-digit product format
- 499670307
- Labeler code
- 49967
- Product ID
- 49967-307_82bf925d-f4a8-400b-a2f8-68f6e9ba94be
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Salicylic Acid
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- L'Oreal USA Products Inc
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-04-15
- Substance
- SALICYLIC ACID
- Active strength
- 5 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49967-307 | 49967-307-03 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 49967-307 | 49967-307-04 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 49967-307 | 49967-307-06 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 49967-307 | 49967-307-07 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 49967-307-06 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 49967-307-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 49967-307-07 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 49967-307-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 49967-307-06 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 49967-307-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 49967-307-07 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 49967-307-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 49967-307-06 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 49967-307-04 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 49967-307-07 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 49967-307-03 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 49967-307-06 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 49967-307-04 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 49967-307-07 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 49967-307-03 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 49967-307-06 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 49967-307-04 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 49967-307-07 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 49967-307-03 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 49967-307-06 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 49967-307-04 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 49967-307-07 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 49967-307-03 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 49967-307-06 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 49967-307-04 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 49967-307-07 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 49967-307-03 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 49967-307-06 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 49967-307-04 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 49967-307-07 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 49967-307-03 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 49967-307-06 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 49967-307-04 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 49967-307-07 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 49967-307-03 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 49967-307-06 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 49967-307-04 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 49967-307-07 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 49967-307-03 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 49967-307-06 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 49967-307-04 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 49967-307-07 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 49967-307-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 49967-307-06 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 49967-307-04 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 49967-307-07 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 49967-307-03 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SALICYLIC ACID | 5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O414PZ4LPZ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 865105 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0db3a8cb-7691-4772-9f7d-15de66098e2e | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49967-307-01 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 200 mL in 1 BOTTLE | GEL | 200 | 10 | |
| 49967-307-02 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 7 mL in 1 PACKET | GEL | 7 | 10 | |
| 49967-307-03 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 50 mL in 1 BOTTLE | GEL | 50 | 10 | |
| 49967-307-04 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 15 mL in 1 BOTTLE | GEL | 15 | 10 | |
| 49967-307-05 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 400 mL in 1 BOTTLE | GEL | 400 | 10 | |
| 49967-307-06 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 50 mL in 1 TUBE | GEL | 50 | 10 | |
| 49967-307-07 | Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing | 15 mL in 1 TUBE | GEL | 15 | 10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 865105 | salicylic acid 0.5 % Medicated Liquid Soap | PSN | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
| 865105 | salicylic acid 5 MG/ML Medicated Liquid Soap | SCD | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
| 865105 | salicylic acid 0.5 % Foaming Cleanser | SY | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
| 865105 | salicylic acid 0.5 % Mask | SY | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
| 865105 | salicylic acid 0.5 % Medicated Liquid Soap | SY | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
| 865105 | salicylic acid 0.5 % Topical Gel Cleanser | SY | 0db3a8cb-7691-4772-9f7d-15de66098e2e | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49967-307-01 | 49967030701 | 200 mL in 1 BOTTLE (49967-307-01) | 200 ml | 2020-04-15 | 0000-00-00 | No | No | Current |
| 49967-307-02 | 49967030702 | 7 mL in 1 PACKET (49967-307-02) | 7 ml | 2020-04-29 | 0000-00-00 | No | No | Current |
| 49967-307-03 | 49967030703 | 50 mL in 1 BOTTLE (49967-307-03) | 50 ml | 2020-08-18 | 0000-00-00 | No | No | Current |
| 49967-307-04 | 49967030704 | 15 mL in 1 BOTTLE (49967-307-04) | 15 ml | 2020-08-18 | 0000-00-00 | No | No | Current |
| 49967-307-05 | 49967030705 | 400 mL in 1 BOTTLE (49967-307-05) | 400 ml | 2022-11-15 | 0000-00-00 | No | No | Current |
| 49967-307-06 | 49967030706 | 50 mL in 1 TUBE (49967-307-06) | 50 ml | 2020-08-18 | 0000-00-00 | No | No | Current |
| 49967-307-07 | 49967030707 | 15 mL in 1 TUBE (49967-307-07) | 15 ml | 2020-08-18 | 0000-00-00 | No | No | Current |